Automated microinjection for zebrafish xenograft models
bioRxiv (Cold Spring Harbor Laboratory)
Abstract
Abstract Zebrafish xenograft models have been increasingly recognized for their ability to predict patient responses to cancer therapeutics, suggesting their potential as diagnostic tools in clinical settings. However, these models require the precise microinjection of cancer cell suspensions in many small and fragile zebrafish larvae. Manual injections are so challenging that, even after months of training, variability in experimental results persists among researchers. This limits the uptake and deployment of zebrafish xenograft models for clinical use and drug discovery. To address this challenge, we have designed, built, and validated an automated microinjection robot. Combined results of injections into the vasculature, perivitelline space, and hindbrain ventricle demonstrated an average injection success rate of approximately 60%, with a larvae survival rate exceeding 70%, comparable to manual injections using a traditional micromanipulator. Notably, the full automated mode was twice as fast as manual injections. This automation of the microinjection process significantly reduces the need for extensive personnel training while it enhances reproducibility, efficiency, and accuracy, paving the way for more extensive use of zebrafish xenograft models in drug discovery and patient diagnostics.
Authors 20
-
Affiliation as printed
Life Science Methods BV, Leiden, the Netherlands
-
Affiliation as printed
Life Science Methods BV, Leiden, the Netherlands
-
Affiliation as printed
Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway
-
Affiliation as printed
ZeClinics SL, Barcelona, Spain
-
Affiliation as printed
BioReperia AB, Linköping, Sweden
-
Leiden University Medical Center
Affiliation as printed
Oncode Institute, Dept. Cell & Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands
-
Leiden University Medical Center
Affiliation as printed
Oncode Institute, Dept. Cell & Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands
-
Leiden University Medical Center
Affiliation as printed
Oncode Institute, Dept. Cell & Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands
-
Affiliation as printed
Life Science Methods BV, Leiden, the Netherlands
-
Affiliation as printed
BioReperia AB, Linköping, Sweden
-
Affiliation as printed
Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway
-
Affiliation as printed
ZeClinics SL, Barcelona, Spain
-
Affiliation as printed
ZeClinics SL, Barcelona, Spain
-
Leiden University Medical Center
Affiliation as printed
Oncode Institute, Dept. Cell & Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands
-
Affiliation as printed
Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway
-
Linköping University · BioReperia AB (Sweden)
Affiliation as printed
BioReperia AB, Linköping, Sweden
Division of Diagnostics and Specialist Medicine, Linköping University, Linköping, Sweden
-
Jan de Sonneville corresponding
Affiliation as printed
Life Science Methods BV, Leiden, the Netherlands
Cited by 2 stored of 2
2 results
No patents citing this paper on Lens.org (checked 2026-10-11).